Found 27 matching trials
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was designed to investigate the 1 year efficacy and safety of th...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study aims to compare the efficacy of three therapies for chronic obst...
Show More Location
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Learn More & Join Trial
Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE4 The purpose of this study is to further figure out differences of glycopyrr...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure PHASE3 This study aims to establish the treatment scheme of Yiqi Huoxue Huatan gra...
Show More Location
Beijing Changping TCM Hospital
Learn More & Join Trial
AMPLIFY - D6571C00001 Duaklir USA Phase III Study PHASE3 This is a multiple dose, randomized, parallel, double-blind, double-dummy, ...
Show More Learn More & Join Trial
Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD) PHASE4 This is a multicentre study with a randomised, parallel group, open-label, ...
Show More Learn More & Join Trial
Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study will assess the efficacy, tolerability and safety of NVA237 comp...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease PHASE3 This study assessed the efficacy and safety of indacaterol (150 µg once dai...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations PHASE3 This study is designed to assess the effect of once-daily QVA149 on COPD ex...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease PHASE2 The purpose of this study is to evaluate the dose-response of different dos...
Show More Location
Chiesi Investigational Site
Learn More & Join Trial